UPDATE -- Ferroglobe PLC Announces Dividend
Feb 08, 2016 12:29 pm UTC| Business
LONDON, Feb. 08, 2016 -- Ferroglobe PLC (Nasdaq:GSM) announced that its Board of Directors on February 3, 2016 declared a quarterlydividend of $0.08 per share payable on March 14, 2016 to shareholders of record at the...
Molecular Diagnostics Reports Bundle - Collection of 4 Reports on Testing and Markets
Feb 08, 2016 12:26 pm UTC| Business
Dublin, Feb. 08, 2016 -- Research and Markets (http://www.researchandmarkets.com/research/l9gmnm/molecular) has announced the addition of the "Molecular Diagnostics Reports Bundle" report to their...
European Cross-Border B2C E-Commerce Report 2015
Feb 08, 2016 12:19 pm UTC| Business
Dublin, Feb. 08, 2016 -- Research and Markets (http://www.researchandmarkets.com/research/87whq3/europe) has announced the addition of the "Europe Cross-Border B2C E-Commerce 2015" report to their...
Global 2016 Report: Stem Cell Research Products, Opportunities, Tools, & Technologies
Feb 08, 2016 12:17 pm UTC| Business
Dublin, Feb. 08, 2016 -- Research and Markets (http://www.researchandmarkets.com/research/5tdqlk/stem_cell) has announced the addition of the "Stem Cell Research Products - Opportunities, Tools, ...
Global 2016 Report: Stem Cell Research Products, Opportunities, Tools, & Technologies
Feb 08, 2016 12:11 pm UTC| Business
Dublin, Feb. 08, 2016 -- Research and Markets (http://www.researchandmarkets.com/research/5tdqlk/stem_cell) has announced the addition of the "Stem Cell Research Products - Opportunities, Tools, ...
Galena Biopharma Announces Notice of Allowance of U.S. Patent for NeuVax™ (nelipepimut-S)
Feb 08, 2016 12:05 pm UTC| Business
SAN RAMON, Calif., Feb. 08, 2016 -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company committed to the development and commercialization of targeted oncology therapeutics that address major unmet medical...
Feb 08, 2016 12:05 pm UTC| Business
- First Dosing of Patients Expected in 1Q 2016 - - Topline Data From Phase 2a Clinical Trial With MAT2203 for the Treatment of Refractory Mucocutaneous Candidiasis Expected in 2016 - BEDMINSTER, N.J., Feb. 08, 2016 ...